Biliary carcinomas: First-line chemoimmunotherapy and marker-based treatment sequence
This Medudy course is a video tutorial for physicians on the topic of “Biliary carcinomas: First-line chemoimmunotherapy and marker-based treatment sequences.” Prof. Dr. Dirk Arnold, Director of the Asklepios Tumor Center Hamburg and of the Department of Oncology, Hematology, Palliative Medicine, Rheumatology, and Pulmonology at the Asklepios Clinic Altona, provides an overview in this video of the […]
First-line treatment of MSI-H/dMMR metastatic colorectal cancer: IO monotherapy or IO combination therapy—a case-based treatment decision
This Medudy course is a video tutorial for physicians on the topic “First-line therapy for MSI-H/dMMR metastatic colorectal cancer: IO monotherapy or IO combination therapy—a case-based treatment decision.” Prof. Dr. Dirk Arnold, Director of the Asklepios Tumor Center Hamburg and of the Department of Oncology, Hematology, Palliative Medicine, Rheumatology, and Pulmonology at the Asklepios Clinic Altona, explains in this video […]
Environmental toxins and Parkinson's disease
This Medudy course is a video tutorial for physicians on the topic of “Environmental Toxins and Parkinson’s Disease.” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. Parkinson’s disease is the fastest-growing neurological disorder worldwide—currently affecting around 12 million people. At the same time […]
ASCO 2026 – Updates on Prostate Cancer
This Medudy course is a conference report for physicians on the topic “ASCO 2026 – Updates on Prostate Cancer.” Prof. Dr. Axel S. Merseburger, Director of the Department of Urology at the Lübeck Campus of the University Medical Center Schleswig-Holstein, will summarize key study highlights from the conference. The results of the Phase III PROTEUS study, which evaluated the efficacy and safety […]
ASCO 2026 – Highlights in Urological Oncology for Clinical Practice
This Medudy course is a video podcast for physicians on the topic “ASCO 2026 – Uro-Oncology Highlights for Clinical Practice.” Prof. Dr. Axel Merseburger (University Medical Center Schleswig-Holstein, Lübeck Campus) and Prof. Dr. Christian Gratzke (University Medical Center Freiburg) summarize what they consider to be the most clinically relevant studies from ASCO 2026 on renal cell, urothelial, and prostate cancer. They discuss, among other things, […]
ASCO 2026 Update – Advanced Ovarian Cancer
This Medudy course is a video podcast for physicians on the topic of “Primary vs. Interval Surgery in Advanced Ovarian Cancer.” Prof. Dr. Sven Mahner and Prof. Dr. Fabian Trillsch discuss the role of surgical therapy in advanced ovarian cancer on the sidelines of the American cancer conference ASCO 2026. The focus is on recent analyses of the TRUST study comparing primary […]
PROTEUS Study: Perioperative Therapy for High-Risk Prostate Cancer
This Medudy course is a video podcast for physicians on the topic “The PROTEUS Study – Perioperative Systemic Therapy for High-Risk Prostate Cancer.” Prof. Dr. Axel Merseburger (Clinical Director and Chairholder, University Medical Center Schleswig-Holstein, Lübeck Campus) speaks with study co-author Prof. Dr. Boris Hadaschik (Clinical Director, University Medical Center Essen, West German Cancer Center) about the PROTEUS study, which was published simultaneously in the New England Journal of Medicine. The global […]
ASCO 2026 – Update on Early-Stage Breast Cancer
This Medudy course is a video podcast for physicians on the topic of “Early-Stage Breast Cancer – Highlights from ASCO 2026.” Prof. Dr. Maggie Banys-Paluchowski (gynecologist, Lübeck) and Prof. Dr. Julia Radosa (Hamburg) summarize the most important studies from the Oral Abstract Session on early-stage breast cancer. In the surgical field, the AXANA study (axillary surgical techniques following neoadjuvant chemotherapy), […]
Advances in the Treatment of Urothelial Carcinoma: The Bispecific ADC Iza-bren for MIUC
This Medudy course is a video tutorial for physicians on the topic “Advances in the Treatment of Urothelial Carcinoma: The Bispecific ADC Iza-bren for MIUC.” Prof. Dr. med. Günter Niegisch, senior physician at the Department of Urology at the University Hospital Düsseldorf and principal investigator of the Izabright-Bladder01 study, discusses the antibody-drug conjugate Iza-bren in the context of advanced urothelial carcinoma […]
Efficacy of the new lutamides in metastatic hormone-sensitive prostate cancer (mHSPC)
This Medudy course is a video tutorial for physicians on the topic of “The Efficacy of New Lutamides in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).” Prof. Dr. Peter Hammerer, Chief Physician at the Department of Urology at Braunschweig Municipal Hospital, presents an overview of the efficacy and clinical classification of the new androgen receptor inhibitors (“lutamides”) in metastatic hormone-sensitive prostate cancer (mHSPC). Topics covered include […]